Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 34 citing Wang: Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis.... (0.09 sec) 

SGK1-mediated fibronectin formation in diabetic nephropathy


Y Feng, Q Wang, Y Wang, B Yard, F Lang - Cell Physiol Biochem, 2005 - content.karger.com
Fax +41 61 306 12 34 E-Mail karger@karger.ch www.karger.com ... Accessible online at:
www.karger.com/journals/net ... Yuxi Feng1,2, Quansheng Wang2, Yumei Wang2, Benito Yard1
and Florian Lang3 ... 15th Medical Clinic, Faculty of Clinical Medicine, University of ...
Cited by 26 - Related articles - BL Direct - All 5 versions

Ras modulation of superoxide activates ERK-dependent fibronectin expression in …


CL Lin, FS Wang, YR Kuo, YT Huang, HC Huang, YC … - Kidney international, 2006 - nature.com
Although previous studies have demonstrated that diabetic nephropathy is attributable to early
extracellular matrix accumulation in glomerular mesangial cells, the molecular mechanism by
which high glucose induces matrix protein deposition remains not fully elucidated. Rat ...
Cited by 22 - Related articles - BL Direct - All 4 versions

Therapeutic potential of angiostatin in diabetic nephropathy

- asnjournals.org
SX Zhang, JJ Wang, K Lu, R Mott, R … - Journal of the American …, 2006 - Am Soc Nephrol
Angiostatin is a proteolytic fragment of plasminogen and a potent angiogenic inhibitor. Previous
studies have shown that angiostatin inhibits retinal neovascularization and reduces retinal vascular
permeability in diabetic retinopathy. Here, it is reported for the first time that angiostatin is ...
Cited by 21 - Related articles - BL Direct - All 6 versions

Salutary Effect of Pigment Epithelium–Derived Factor in Diabetic Nephropathy


JJ Wang, SX Zhang, R Mott, RR Knapp, W Cao, K Lau, … - Diabetes, 2006 - Am Diabetes Assoc
Diabetic nephropathy is a major complication of diabetes and a leading cause of end-stage renal
diseases in the US Pigment epithelium–derived factor (PEDF) is a potent angiogenic inhibitor
that has been extensively studied in diabetic retinopathy. Recently, we reported that ...
Cited by 21 - Related articles - BL Direct - All 5 versions

Role of AGEs in diabetic nephropathy


K Fukami, S Yamagishi, S Ueda, S … - Current pharmaceutical …, 2008 - ingentaconnect.com
Abstract: Diabetic nephropathy is the most common cause of end-stage renal disease in the
world, and accounts for a significant increase in morbidity and mortality in patients with
diabetes. Therapeutic options such as strict blood pressure and/or glycemic control are ...
Cited by 15 - Related articles - BL Direct - All 3 versions

The discovery of biomarkers for type 2 diabetic nephropathy by serum proteome …


EH Cho, MR Kim, HJ Kim, DY Lee, PK Kim … - PROTEOMICS …, 2007 - interscience.wiley.com
Diabetic nephropathy (DN) is a serious kidney complication of diabetes, and constitutes the leading
cause of end-stage renal disease. The earliest clinical evidence of DN is microalbuminuria, a
term which refers to the appearance of small but abnormal amounts of albumin in the ...
Cited by 8 - Related articles - BL Direct

Increased serum pigment epithelium-derived factor is associated with …


AJ Jenkins, SX Zhang, KG Rowley, CS Karschimkus, … - Diabetic …, 2007 - pt.wkhealth.com
1 A subset of these data was presented as an oral presentation at the 2006 Australian Diabetes
Society Annual Meeting, and an abstract to the 2006 American Diabetes Society Meeting was
published in Diabetes, 2006; 55 (suppl. 1), A504. ... 2 These authors contributed equally ...
Cited by 10 - Related articles - BL Direct - All 5 versions

Anti-inflammatory effects of pigment epithelium-derived factor in diabetic …

- physiology.org [PDF] 
JJ Wang, SX Zhang, R Mott, Y Chen, RR … - American Journal of …, 2008 - Am Physiological Soc
47 articles, 24 of which you can access free at: This article cites http://ajprenal.physiology.org
/cgi/content/full/294/5/F1166#BIBL ... 1 other HighWire hosted article: This article has been cited
by ... [PDF] [Full Text] , July 1, 2009; 58 (7): 1471-1478. Diabetes T. Nakagawa, T. ...
Cited by 7 - Related articles - BL Direct - All 4 versions

Down-regulation of angiogenic inhibitors: a potential pathogenic mechanism for …


J Ma, SX Zhang, JJ Wang - Current Diabetes Reviews, 2005 - ingentaconnect.com
Abstract: Diabetic retinopathy (DR) and diabetic nephropathy (DN) are the most common microvascular
complications of diabetes. DR is a leading cause of blindness, and DN is a major cause of
end-stage renal diseases. Diabetic macular edema (DME) resulting from increased ...
Cited by 2 - Related articles - BL Direct - All 2 versions

Pigment epithelium-derived factor (PEDF): its potential therapeutic implication in …


S Yamagishi, T Matsui, K Nakamura, S Ueda, Y … - Current Drug …, 2008 - ingentaconnect.com
Abstract: Diabetic micro- and macroangiopathies are leading causes of acquired blindness,
end-stage renal failure and accelerated atherosclerosis, which could account for disabilities
and high mortality rates in patients with diabetes. Recent large landmark clinical studies ...
Cited by 2 - Related articles - All 2 versions


Result Page: 

1

2

3

4

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google